The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Rα complexes
Open accessAbstract
Cytotoxic lymphocytes such as natural killer (NK) and CD8 T cells play important roles in immunosurveillance by killing virally infected or malignant cells. The homeostatic cytokine, IL-15, promotes the development, function, and survival of NK and CD8 T cells. IL-15 is normally presented in trans as a surface complex with IL-15 receptor-alpha-chain (IL-15Rα) by dendritic cells (DCs) and monocytes. Signaling by IL-15 occurs via the IL-2/IL-15 receptor β-chain (CD122) which is expressed primarily by NK1.1 + cells and CD8 T cells. The use of preformed complexes of IL-15 with soluble IL-15Rα complexes to boost the effector function of CD122 + cytolytic lymphocytes such as NK and CD8 T cells has recently gained considerable attention. Here we describe the impact of transient and prolonged in vivo stimulation by IL-15/IL-15Rα complexes on NK and CD8 T cells. Whereas transitory stimulation increased the number of activated NK cells and significantly enhanced their effector function, prolonged stimulation by IL-15/IL-15Rα complexes led to a marked accumulation of mature NK cells with considerably impaired activation, cytotoxicity, and proliferative activity, and an altered balance of activating and inhibitory receptors. In contrast to NK cells, CD8 T cells exhibited an activated phenotype and robust T cell receptor stimulation and effector function upon chronic stimulation with IL-15/IL-15Rα complexes. Thus, prolonged stimulation with the strong activating signal leads to a preferential accrual of mature NK cells with altered activation and diminished functional capacity. These findings point to a negative feedback mechanism to preferentially counterbalance excessive NK cell activity and may have important implications for cytokine immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The cytokines IL-21 and IL-15 have been suggested to substantially boost NK cell-mediated immunity against cancer cells222–225.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [224]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769 · cited 3×
“Target recognition and effector function by NK cells are known to be controlled by a balance of activating and inhibitory receptors including members of Ly49 (mouse)/KIR (human) family, CD94/NKG2, natural cytotoxicity receptors, and Fc receptors, as well as costimulatory receptors that are essential for tuning their r…”
BackgroundMolecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.006 · Cited by 2,103 · cited 1×
“Notably, PD1 and KLRG1, two molecules associated with chronic stimulation in T cells (39), were low to negative on CD8 T cells in all conditions (Fig.”
BackgroundReversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice
Kennedy, M. K., Glaccum, M., Brown, S. N., Butz, E. A., Viney, J. L., Embers, M., Matsuki, N., Charrier, K., Sedger, L., Willis, C. R., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.771 · Cited by 1,634 · cited 1×
“Development of NK cells from precursors in bone marrow depends on the presence of this cytokine as shown by a lack of NK cells in IL-15 and γ-chain knockout mice (17, 18).”
BackgroundAdaptive immune features of natural killer cells
Sun, J. C., Beilke, J. N., & Lanier, L. L. (2009) · Nature · doi:10.1038/nature07665 · Cited by 1,619 · cited 3×
“Next we evaluated NK cell activation following stimulation with IL-15/IL-15Rα complexes by flow cytometry using surface markers known to be up-regulated on NK cells upon activation (24, 29, 30).”
BackgroundMethodMolecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.006 · Cited by 1,354
Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P., & Van Ginderachter, J. A. (2008) · Blood · doi:10.1182/blood-2007-07-099226 · Cited by 1,234 · cited 1×
“We also determined that various regulatory molecules known to inhibit NK cell function (11, 37, 38), such as IFNγ, nitric oxide, and IL-12p40 (Fig.”
BackgroundIL-15Rα Recycles and Presents IL-15 In trans to Neighboring Cells
Dubois, S., Mariner, J., Waldmann, T. A., & Tagaya, Y. (2002) · Immunity · doi:10.1016/s1074-7613(02)00429-6 · Cited by 913
Natural killer cells, viruses and cancer
Cerwenka, A., & Lanier, L. L. (2001) · Nature Reviews Immunology · doi:10.1038/35095564 · Cited by 875 · cited 2×
“Activation stimuli normally endow NK cells with cytotoxic function by up-regulating the expression of granzyme B and perforin and the production of effector cytokines such as IFNγ, TNFα, and granulocyte macrophage colony-stimulating factor (GM-CSF) (1, 2).”
BackgroundMaturation of mouse NK cells is a 4-stage developmental program
Chiossone, L., Chaix, J., Fuseri, N., Roth, C., Vivier, E., & Walzer, T. (2009) · Blood · doi:10.1182/blood-2008-10-187179 · Cited by 787 · cited 1×
“NK cells can be classified into four main developmental stages on the basis of surface CD11b and CD27 levels (32, 33).”
BackgroundNatural Killer Cell Signaling Pathways
Vivier, E., Nunès, J. A., & Vély, F. (2004) · Science · doi:10.1126/science.1103478 · Cited by 751
CD27 Dissects Mature NK Cells into Two Subsets with Distinct Responsiveness and Migratory Capacity
Hayakawa, Y., & Smyth, M. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1517 · Cited by 749 · cited 1×
“NK cells can be classified into four main developmental stages on the basis of surface CD11b and CD27 levels (32, 33).”
BackgroundNatural-killer cells and dendritic cells: “l'union fait la force”
Walzer, T., Dalod, M., Robbins, S. H., Zitvogel, L., & Vivier, E. (2005) · Blood · doi:10.1182/blood-2005-03-1154 · Cited by 634
Oppenheim, D. E., Roberts, S. J., Clarke, S. L., Filler, R., Lewis, J. M., Tigelaar, R. E., Girardi, M., & Hayday, A. C. (2005) · Nature Immunology · doi:10.1038/ni1239 · Cited by 454
Oliviero, B., Varchetta, S., Paudice, E., Michelone, G., Zaramella, M., Mavilio, D., De Filippi, F., Bruno, S., & Mondelli, M. U. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.047 · Cited by 412 · cited 1×
“However, NK cell hyporesponsiveness has been observed upon prolonged stimulation with strong immune activating signals (5–11) and in various chronic inflammatory and autoimmune diseases including chronic hepatitis (12), tuberculosis (13), AIDS (14), diabetes (15), and systemic onset juvenile rheumatoid arthritis (16).”
BackgroundIL-15/IL-15 receptor biology: A guided tour through an expanding universe
BUDAGIAN, V, BULANOVA, E., PAUS, R., & BULFONEPAUS, S. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.05.001 · Cited by 385 · cited 1×
“This outcome highlights the importance of strict regulation of IL-15 expression and transpresentation under physiological conditions (41).”
BackgroundCombined IL-15/IL-15Rα Immunotherapy Maximizes IL-15 Activity In Vivo
Stoklasek, T. A., Schluns, K. S., & Lefrançois, L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6072 · Cited by 366
NK Cell Maturation and Peripheral Homeostasis Is Associated with KLRG1 Up-Regulation
Huntington, N. D., Tabarias, H., Fairfax, K., Brady, J., Hayakawa, Y., Degli-Esposti, M. A., Smyth, M. J., Tarlinton, D. M., & Nutt, S. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.4764 · Cited by 340 · cited 1×
“Becausemature NK cells also express KLRG1 (23, 34), we next analyzed CD11b vs.”
BackgroundVosshenrich, C. A. J., Ranson, T., Samson, S. I., Corcuff, E., Colucci, F., Rosmaraki, E. E., & Di Santo, J. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1213 · Cited by 283 · cited 1×
“Development of NK cells from precursors in bone marrow depends on the presence of this cytokine as shown by a lack of NK cells in IL-15 and γ-chain knockout mice (17, 18).”
BackgroundBunt, S. K., Clements, V. K., Hanson, E. M., Sinha, P., & Ostrand-Rosenberg, S. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0708446 · Cited by 277
Huntington, N. D., Puthalakath, H., Gunn, P., Naik, E., Michalak, E. M., Smyth, M. J., Tabarias, H., Degli-Esposti, M. A., Dewson, G., Willis, S. N., et al. (2007) · Nature Immunology · doi:10.1038/ni1487 · Cited by 268 · cited 1×
“However, continual stimulation by IL-15, which is a well-known survival signal for NK cells, prevented the natural turnover of developmentally mature NK cells (40).”
BackgroundRegulation of Cellular and Humoral Immune Responses by the SLAM and SAP Families of Molecules
Ma, C. S., Nichols, K. E., & Tangye, S. G. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141651 · Cited by 264 · cited 1×
“NK cell expression of various activating and inhibitory receptors (3, 31) was then characterized.”
BackgroundVillanueva, J., Lee, S., Giannini, E. H., Graham, T. B., Passo, M. H., Filipovich, A., & Grom, A. A. (2004) · Arthritis Res Ther · doi:10.1186/ar1453 · Cited by 243 · cited 1×
“However, NK cell hyporesponsiveness has been observed upon prolonged stimulation with strong immune activating signals (5–11) and in various chronic inflammatory and autoimmune diseases including chronic hepatitis (12), tuberculosis (13), AIDS (14), diabetes (15), and systemic onset juvenile rheumatoid arthritis (16).”
BackgroundDevulder, B. (1994) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(05)82117-4 · Cited by 208
Dubois, S., Patel, H. J., Zhang, M., Waldmann, T. A., & Müller, J. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2099 · Cited by 205
Continuous engagement of a self-specific activation receptor induces NK cell tolerance
Tripathy, S. K., Keyel, P. A., Yang, L., Pingel, J. T., Cheng, T. P., Schneeberger, A., & Yokoyama, W. M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072446 · Cited by 176
Epardaud, M., Elpek, K. G., Rubinstein, M. P., Yonekura, A.-R., Bellemare-Pelletier, A., Bronson, R., Hamerman, J. A., Goldrath, A. W., & Turley, S. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0045 · Cited by 167
Self-citationRobbins, S. H., Nguyen, K. B., Takahashi, N., Mikayama, T., Biron, C. A., & Brossay, L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2585 · Cited by 159 · cited 3×
“So-called “endstage NK cells” are characterized by reduced proliferative capacity, diminished functional potential, and elevated apoptosis (23, 35).”
BackgroundCD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells
Vosshenrich, C. A. J., Lesjean‐Pottier, S., Hasan, M., Goff, O. R.-L., Corcuff, E., Mandelboim, O., & Santo, J. P. D. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071451 · Cited by 157 · cited 1×
“Next we evaluated NK cell activation following stimulation with IL-15/IL-15Rα complexes by flow cytometry using surface markers known to be up-regulated on NK cells upon activation (24, 29, 30).”
MethodTolerance of NK cells encountering their viral ligand during development
Sun, J. C.-Y., & Lanier, L. L. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072448 · Cited by 125
Koblish, H. K., Hunter, C. A., Wysocka, M., Trinchieri, G., & Lee, W. M. F. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1603 · Cited by 122 · cited 1×
“We also determined that various regulatory molecules known to inhibit NK cell function (11, 37, 38), such as IFNγ, nitric oxide, and IL-12p40 (Fig.”
BackgroundDendritic cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation
Stonier, S. W., Ma, L. J., Castillo, E. F., & Schluns, K. S. (2008) · Blood · doi:10.1182/blood-2008-05-156307 · Cited by 121
Miyake, T., Kumagai, Y., Kato, H., Guo, Z., Matsushita, K., Satoh, T., Kawagoe, T., Kumar, H., Jang, M. H., Kawai, T., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901500 · Cited by 115
Expansion and Contraction of the NK Cell Compartment in Response to Murine Cytomegalovirus Infection
Robbins, S. H., Tessmer, M. S., Mikayama, T., & Brossay, L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.259 · Cited by 114
Vaknin, I., Blinder, L., Wang, L., Gazit, R., Shapira, E., Genina, O., Pines, M., Pikarsky, E., & Baniyash, M. (2007) · Blood · doi:10.1182/blood-2007-07-100404 · Cited by 105 · cited 1×
“We also determined that various regulatory molecules known to inhibit NK cell function (11, 37, 38), such as IFNγ, nitric oxide, and IL-12p40 (Fig.”
BackgroundDistinct Phenotype and Function of NK Cells in the Pancreas of Nonobese Diabetic Mice
Brauner, H., Elemans, M., Lemos, S., Broberger, C., Holmberg, D., Flodström‐Tullberg, M., Kärre, K., & Höglund, P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0804358 · Cited by 99 · cited 1×
“However, NK cell hyporesponsiveness has been observed upon prolonged stimulation with strong immune activating signals (5–11) and in various chronic inflammatory and autoimmune diseases including chronic hepatitis (12), tuberculosis (13), AIDS (14), diabetes (15), and systemic onset juvenile rheumatoid arthritis (16).”
BackgroundCastillo, E. F., Stonier, S. W., Frasca, L., & Schluns, K. S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900719 · Cited by 96 · cited 1×
“During the initial steps of immune activation, NK cells are exposed to IL-15 transpresented via IL-15Rα on DCs, an encounter that promotes their expansion and survival throughout the immune response (19).”
BackgroundNatural Killer Cell Immune Responses
Yokoyama, W. M. (2005) · Immunologic Research · doi:10.1385/ir:32:1-3:317 · Cited by 88
Talmadge, J. E., Herberman, R. B., Chirigos, M. A., Maluish, A. E., Schneider, M., Adams, J. S., Philips, H., Thurman, G. B., Varesio, L., Long, C., et al. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.4.2483 · Cited by 85
Bozzano, F. M., Costa, P., Passalacqua, G., Dodi, F., Ravera, S., Pagano, G., Canonica, G. W., Moretta, L., & Maria, A. D. (2009) · International Immunology · doi:10.1093/intimm/dxp046 · Cited by 65 · cited 1×
“However, NK cell hyporesponsiveness has been observed upon prolonged stimulation with strong immune activating signals (5–11) and in various chronic inflammatory and autoimmune diseases including chronic hepatitis (12), tuberculosis (13), AIDS (14), diabetes (15), and systemic onset juvenile rheumatoid arthritis (16).”
BackgroundIannello, A., Débbeche, O., Samarani, S., & Ahmad, A. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0907649 · Cited by 63 · cited 2×
“However, NK cell hyporesponsiveness has been observed upon prolonged stimulation with strong immune activating signals (5–11) and in various chronic inflammatory and autoimmune diseases including chronic hepatitis (12), tuberculosis (13), AIDS (14), diabetes (15), and systemic onset juvenile rheumatoid arthritis (16).”
BackgroundAdjuvants targeting innate and adaptive immunity synergize to enhance tumor immunotherapy
Verdeil, G., Marquardt, K., Surh, C. D., & Sherman, L. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805054105 · Cited by 52
Sague, S. L., Tato, C. M., Puré, E., & Hunter, C. A. (2004) · Journal of Interferon & Cytokine Research · doi:10.1089/107999004323065093 · Cited by 44 · cited 1×
“Next we evaluated NK cell activation following stimulation with IL-15/IL-15Rα complexes by flow cytometry using surface markers known to be up-regulated on NK cells upon activation (24, 29, 30).”
MethodSaito, T., Ruffmann, R., Welker, R. D., Herberman, R. B., & Chirigos, M. A. (1985) · Cancer Immunology Immunotherapy · doi:10.1007/bf00199721 · Cited by 24
Cited by
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277
Liu, E., Tong, Y., Dotti, G., Shaim, H., Savoldo, B., Mukherjee, M., Orange, J., Wan, X., Lu, X., Reynolds, A., et al. (2018) · Leukemia · doi:10.1038/leu.2017.226 · Cited by 824
“Moreover, in contrast to a previous report in murine NK cells that sustained stimulation with IL-15/IL-15R-α complexes induces dysfunction,(29) human iC9/CAR.”
Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade
da Silva, I. P., Gallois, A., Jimenez-Baranda, S., Khan, S., Anderson, A. C., Kuchroo, V. K., Osman, I., & Bhardwaj, N. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0171 · Cited by 424
Wrangle, J. M., Velcheti, V., Patel, M. R., Garrett-Mayer, E., Hill, E. G., Ravenel, J. G., Miller, J. S., Farhad, M., Anderton, K., Lindsey, K., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30148-7 · Cited by 412
Self-citationContinuous treatment with IL-15 exhausts human NK cells via a metabolic defect
Felices, M., Lenvik, A. J., McElmurry, R., Chu, S., Hinderlie, P., Bendzick, L., Geller, M. A., Tolar, J., Blazar, B. R., & Miller, J. S. (2018) · JCI Insight · doi:10.1172/jci.insight.96219 · Cited by 272
Metadata
- Authors
- Elpek, K. G., Rubinstein, M. P., Bellemare-Pelletier, A., Goldrath, A. W., & Turley, S. J.
- Affiliations
- Dana-Farber Cancer Institute (US)
- University of California San Diego (US)
- Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA 02115;
- Harvard University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2010-11-22
- Volume
- 107
- Issue
- 50
- Pages
- 21647-21652
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3003106
- OpenAlex
- W2031976232
- Cited by
- 130
- References
- 43
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 7 · 2023: 7 · 2022: 6 · 2021: 10 · 2020: 13 · 2019: 11 · 2018: 9 · 2017: 9 · 2016: 7 · 2015: 6 · 2014: 14 · 2013: 4 · 2012: 8
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI067545, AI067545, R01AI072117, R37AI067545)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- natural killer cells, CD8+ T cells, IL-15, IL-15 receptor alpha, NK cell homeostasis, NK cell activation, cytotoxicity, CD122, activating and inhibitory receptors, negative feedback regulation, T cell receptor stimulation, cytokine therapy
- MeSH terms
- Animals, Dendritic Cells, Humans, Killer Cells, Natural, Lymphocyte Activation, Mice, Inbred C57BL, Monocytes, Interleukin-15, Cell Proliferation, Mice, Interleukin-15 Receptor alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.